Harvard Pilgrim Health Care Partners with Physicians to Close Costly Gaps in Care
Physicians to use health analytics technology Data Diagnostics® from Quest Diagnostics and Inovalon to help improve patient care and financial performance
Madison, N.J. – February 16, 2017 – Harvard Pilgrim Health Care now offers physicians Data Diagnostics®, a point-of-care health analytics technology from Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) that is designed to help close costly gaps in care and improve health outcomes.
Accessible through a physician’s existing electronic health record (EHR), Data Diagnostics® produces reports, often in seconds, that help inform clinical decisions, diagnostic coding and other actions to help improve quality of care and reimbursement. Physicians can order patient-specific Data Diagnostics® reports through their EHR for eligible HPHC patients in Connecticut, Massachusetts, New Hampshire and Maine. No new technology, and minimal training, is required to order reports for patients.
HPHC is committed to providing tools that support physician’s access to relevant data within the physicians current workflow. Data Diagnostics® gives physicians the ability to order and access reports in real time, so they can use the information to more effectively care for their patients with evidence-based criteria that reflect good medical practice during the patient visit. The reports employ the EHR’s existing data on the patient as well as patient-specific information from Quest’s 20 billion lab test results and Inovalon’s 139 million unique patients within their MORE2 Registry® clinical datasets.
“One of Harvard Pilgrim’s chief goals is to empower our physicians to succeed under value-based care and innovative risk-sharing models,” said Gaurish Chandrashekhar, director of revenue management for HPHC. “We believe Data Diagnostics® may help enable this transition by supporting more accurate clinical coding, which is vital to risk adjustment accuracy and appropriate reimbursement, as well as improved quality. We expect this tool will strengthen our relationships with physicians while simultaneously improving provider-patient interactions, which is a win-win-win scenario.”
Accurate and complete data supports high quality patient care as well as reimbursement under value-based care models that tie compensation to quality and outcomes rather than individual medical services.
“The shift from volume to value is all about providing better care,” said David Freeman, general manager, information ventures, Quest Diagnostics. “Harvard Pilgrim Health Care has a track record of innovation in health care, and recognizes that good care and cost efficiency often go hand in hand. We look forward to providing Data Diagnostics® and its actionable insights to HPHC-serving physicians to aid the delivery of quality care for patients.
About Data Diagnostics®
Data Diagnostics®, a joint solution offered by Quest Diagnostics and Inovalon, is a point-of-care health analytics technology that produces patient-specific reports in real time to help physicians easily identify and address gaps in quality, risk, utilization and medical history. Reports draw from information in the physician’s EHR as well as data from Quest’s 20 billion clinical laboratory test results and Inovalon’s clinical datasets on more than 139 million Americans. Physicians can order Data Diagnostics® reports in their existing workflow and EHR, receiving an easy to read actionable report often within seconds. Data Diagnostics® has won several industry awards, including the Best in Biz Most Innovative Product of the Year for Healthcare Award. Data Diagnostics® is part of the Quest Diagnostics Quanum™ suite of healthcare information and technology solutions. www.QuestDiagnostics.com/DataDiagnostics
About Harvard Pilgrim Health Care
Harvard Pilgrim is a not-for-profit health services company that, along with its subsidiaries, is improving the well-being of its 2.7 million customers. Harvard Pilgrim’s flagship health plans in New England provide health coverage to 1.3 million members, while another 1.4 million individuals are served through Health Plans, Inc., a subsidiary that provides integrated care management, health coaching and plan administration solutions to self-funded employers nationwide.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 43,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.
Inovalon is a leading technology company providing cloud-based platforms empowering a data-driven transformation from volume-based to value-based models throughout the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and industry-leading subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon's unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Providing technology that supports nearly 500 healthcare organizations, Inovalon's platforms are informed by data pertaining to more than 837,000 physicians, 354,000 clinical facilities, and more than 139 million Americans. Data Diagnostics® is the intellectual property of Inovalon. For more information, visit www.inovalon.com or www.datadiagnostics.com.
Rachel Robbins, Greenough (Media): 617-275-6521, email@example.com
Wendy Bost, Quest Diagnostics (Media): 973-520-2800
Shawn Bevec, Quest Diagnostics (Investors): 973-520-2900